Mustang Bio (MBIO) Net Equity Issued and Repurchased (2016 - 2025)
Mustang Bio (MBIO) posted quarterly Net Equity Issued and Repurchased of $7.4 million for Q4 2025, up 480.66% year-over-year from $1.3 million in Q4 2024, and up 1133.33% quarter-over-quarter from $600000.0 in Q1 2025.
Mustang Bio (MBIO) Net Equity Issued and Repurchased (2016 - 2025) Analysis & Trends
Mustang Bio (MBIO) has reported Net Equity Issued and Repurchased for 8 consecutive years, with $7.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased rose 480.66% year-over-year to $7.4 million; the TTM figure through Dec 2025 stood at $8.0 million (up 226.0% YoY), while the FY2025 annual figure was $8.0 million, up 100.0% from the prior year.
- Net Equity Issued and Repurchased improved to $7.4 million in Q4 2025 per MBIO's latest filing, from $600000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $48.4 million in Q1 2021 and bottomed at -$48.4 million in Q2 2021.
- Historically, Net Equity Issued and Repurchased has averaged $1.5 million across 4 years, with a median of $600000.0 in 2025.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 868.0% in 2021 and fell as far as 250.17% in 2021.
- Mustang Bio's Net Equity Issued and Repurchased stood at -$48.4 million in 2021, then surged by 108.75% to $4.2 million in 2023, then slumped by 145.9% to -$1.9 million in 2024, then soared by 480.66% to $7.4 million in 2025.
- Business Quant data shows MBIO's Net Equity Issued and Repurchased at $7.4 million in Q4 2025, $600000.0 in Q1 2025, and -$1.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.40 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2023 | 4.24 Mn |
| Dec 31, 2023 | 4.24 Mn |
| Sep 30, 2023 | 163,000.00 |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2021 | -48.40 Mn |
| Jun 30, 2021 | -48.40 Mn |
| Mar 31, 2021 | 48.40 Mn |
| Mar 31, 2021 | 48.40 Mn |
| Jun 30, 2020 | 32.23 Mn |
| Jun 30, 2020 | 32.23 Mn |
| Mar 31, 2020 | 5.00 Mn |
| Mar 31, 2020 | 5.00 Mn |
| Jun 30, 2019 | 18.01 Mn |
| Jun 30, 2019 | 18.01 Mn |